In this video, the first in a 5-part series, panelists discuss recent advancements in bronchiectasis management.
Back
RX Review: A New Era of Disease-Modifying Therapy for Bronchiectasis
A 5-part video series tackling updates and unmet needs in bronchiectasis in the wake of the August 2025 approval of bronchiectasis.
RX Review: A New Era of Disease-Modifying Therapy for Bronchiectasis
Episodes
All
All
In this video, the second in a 5-part series, panelists discuss the recent FDA approval of brensocatib.
In this video, the third in a 5-part series, panelists discuss data from the phase 3 ASPEN trial.
In this video, the fourth in a 5-part series, panelists discuss who may benefit from brensocatib's approval.
In this video, the last in a 5-part series, panelists discuss their future outlook on bronchiectasis management.
Advertisement
Advertisement
Trending on HCPLive
1
Targeting Gut Candida to Treat IBD, With Iliyan D. Iliev, PhD
2
Half-Life vs. Real Life: How Real-World Evidence Is Reframing Wet AMD Treatment
3
ProACt Data Show Early Functional Gains with Adjunctive Cariprazine In MDD
4
Why Clinicians Should Not Wait to Augment Inadequate Response in MDD
5